The spot makes lofty claims about weight-loss drugs offered by the telehealth company Hims & Hers, but says little about ...

An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use ...

Telehealth company Hims & Hers' first Super Bowl ad is provocative and effective in building awareness of its weight loss ...

Even folks who aren't into football tune into the Super Bowl for its ads, but this year there's some "big drama" around one ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

The Grammy winner announced on Thursday that she was launching Kelly Clarkson: Studio Sessions - The Las Vegas Residency, ...

AbbVie’s Skyrizi was responsible for the highest TV advertising outlay in pharma in most months of 2024, but 2025 is starting ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Telehealth company Him & Hers Health is taking a very different approach to its Super Bowl ad this year - as its new ...

(CNN) — Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated ...